Retiro De Equipo (Recall) de Brain Metastases v1.0.0 and Adaptive Hybrid Surgery Analysis (AHSA) v1.0.0(Used for Linac based radiation treatment planning of cranial, head and neck, and extracranial lesions)

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Brainlab Australia Pty Ltd.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    RC-2016-RN-00046-2
  • Clase de Riesgo del Evento
    Class I
  • Fecha de inicio del evento
    2016-01-15
  • País del evento
  • Fuente del evento
    DHTGA
  • URL de la fuente del evento
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    Brainlab image fusion is used for co-registration of medical images. when loading the fusion result in affected devices, under specific circumstances, the fusion result stored by image fusion is disregarded. instead the image datasets are co-registered based on the scanner-inherent fusion that can potentially result from acquiring the images in one imaging session. in consequence, the image datasets may become shifted e.G. organs at risk or planning target volume, may become shifted in relation to their anatomical position. while using brain metastases 1.0.0, if the shifted objects are not recognised by the user before the plan is used for treatment and the deviation exceeds clinically acceptable limits, this could result in ineffective radiation treatment. while using ahsa 1.0.0, the incorrect information displayed can have an effect on clinical decisions. in a worst case scenario, this can mislead the clinician in assessing the extent of tumour resection during surgery.
  • Acción
    Brainlab will implement a software update for the affected systems. In the interim, users of affected systems are advised to adhere to the following: If possible do not use image datasets with an identical coordinate system (i.e. same frame of reference information), unless the scanner fusion is acceptable to be approved in Image Fusion. Always carefully review and verify the fusion result and all objects for correctness and validity in Brain Metastases or Adaptive Hybrid Surgery Analysis. Specifically if the error message is displayed by the software, review the position of all objects in the CT used for treatment planning and in the image datasets with the same frame of reference. Please note that the error will not be visible in SmartBrush, Image Fusion and DICOM Viewer. Always verify the fusion result and correct position of objects in Brain Metastases or Adaptive Hybrid Surgery Analysis.

Device

  • Modelo / Serial
    Brain Metastases v1.0.0 and Adaptive Hybrid Surgery Analysis (AHSA) v1.0.0(Used for Linac based radiation treatment planning of cranial, head and neck, and extracranial lesions)ARTG Number: 230067
  • Manufacturer

Manufacturer